Deep learning regressor model based on nigrosome MRI in Parkinson syndrome effectively predicts striatal dopamine transporter-SPECT uptake
Authors:
Open Access
- 20 May 2023
- journal article
- research article
- Published by Springer Nature in Neuroradiology
- Vol. 65 (7) , 1101-1109
Abstract
Purpose: Nigrosome imaging using susceptibility-weighted imaging (SWI) and dopamine transporter imaging using 123I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)-nortropane (123I-FP-CIT) single-photon emission computerized tomography (SPECT) can evaluate Parkinsonism. Nigral hyperintensity from nigrosome-1 and striatal dopamine transporter uptake are reduced in Parkinsonism; however, quantification is only possible with SPECT. Here, we aimed to develop a deep-learning-based regressor model that can predict striatal 123I-FP-CIT uptake on nigrosome magnetic resonance imaging (MRI) as a biomarker for Parkinsonism. Methods: Between February 2017 and December 2018, participants who underwent 3 T brain MRI including SWI and 123I-FP-CIT SPECT based on suspected Parkinsonism were included. Two neuroradiologists evaluated the nigral hyperintensity and annotated the centroids of nigrosome-1 structures. We used a convolutional neural network-based regression model to predict striatal specific binding ratios (SBRs) measured via SPECT using the cropped nigrosome images. The correlation between measured and predicted SBRs was evaluated. Results: We included 367 participants (203 women (55.3%); age, 69.0 ± 9.2 [range, 39–88] years). Random data from 293 participants (80%) were used for training. In the test set (74 participants [20%]), the measured and predicted 123I-FP-CIT SBRs were significantly lower with the loss of nigral hyperintensity (2.31 ± 0.85 vs. 2.44 ± 0.90) than with intact nigral hyperintensity (4.16 ± 1.24 vs. 4.21 ± 1.35, P < 0.01). The sorted measured 123I-FP-CIT SBRs and the corresponding predicted values were significantly and positively correlated (ρc = 0.7443; 95% confidence interval, 0.6216–0.8314; P < 0.01). Conclusion: A deep learning-based regressor model effectively predicted striatal 123I-FP-CIT SBRs based on nigrosome MRI with high correlation using manually-measured values, enabling nigrosome MRI as a biomarker for nigrostriatal dopaminergic degeneration in Parkinsonism.Keywords
Funding Information
- National Research Foundation of Kore (2022R1F1A1064530)
- Seoul National University Bundang Hospital Research Fund (02-2021-0015)
This publication has 42 references indexed in Scilit:
- Susceptibility map‐weighted imaging (SMWI) for neuroimagingMagnetic Resonance in Medicine, 2013
- The wide clinical spectrum and nigrostriatal dopaminergic damage in spinocerebellar ataxia type 6Journal of Neurology, Neurosurgery & Psychiatry, 2010
- Second consensus statement on the diagnosis of multiple system atrophyNeurology, 2008
- How common are the “common” neurologic disorders?Neurology, 2007
- Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECTMovement Disorders, 2004
- Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practiceMovement Disorders, 2003
- The substantia nigra of the human brainBrain, 1999
- The substantia nigra of the human brainBrain, 1999
- Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)Neurology, 1996
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992